|
AU722196B2
(en)
*
|
1995-08-30 |
2000-07-27 |
Genzyme Corporation |
Chromatographic purification of adenovirus and AAV
|
|
US20020088014A1
(en)
*
|
1996-05-31 |
2002-07-04 |
Xiangming Fang |
Minimal adenovirus mediated recombinant vaccine
|
|
CZ438398A3
(cs)
|
1996-07-01 |
1999-03-17 |
Rhone-Poulenc Rorer S. A. |
Způsob přípravy rekombinantních adenovirů
|
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
WO1998022588A2
(en)
|
1996-11-20 |
1998-05-28 |
Introgen Therapeutics, Inc. |
An improved method for the production and purification of adenoviral vectors
|
|
US6261823B1
(en)
|
1996-12-13 |
2001-07-17 |
Schering Corporation |
Methods for purifying viruses
|
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US6989264B2
(en)
*
|
1997-09-05 |
2006-01-24 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
JP4303418B2
(ja)
*
|
1997-10-24 |
2009-07-29 |
ライフ テクノロジーズ コーポレーション |
組換え部位を有する核酸を使用する組換えクローニング
|
|
US7705602B2
(en)
*
|
1997-11-03 |
2010-04-27 |
Midtronics, Inc. |
Automotive vehicle electrical system diagnostic device
|
|
US20040204381A1
(en)
*
|
1997-11-12 |
2004-10-14 |
Moskal Joseph R |
Detection and treatment of glyco-enzyme-related disease
|
|
US6899870B1
(en)
*
|
1998-03-11 |
2005-05-31 |
Board Of Regents, The University Of Texas System |
Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery
|
|
EP1073721B1
(en)
*
|
1998-04-22 |
2005-08-31 |
Genvec, Inc. |
Efficient purification of adenovirus
|
|
WO2000022152A1
(en)
*
|
1998-10-13 |
2000-04-20 |
Avigen, Inc. |
Compositions and methods for producing recombinant adeno-associated virus
|
|
US7691370B2
(en)
*
|
1998-10-15 |
2010-04-06 |
Canji, Inc. |
Selectivity replicating viral vector
|
|
US6689600B1
(en)
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
ES2323991T3
(es)
*
|
1998-11-16 |
2009-07-28 |
Introgen Therapeutics, Inc. |
Formulacion de adenovirus para terapia genica.
|
|
US7148035B1
(en)
*
|
1998-11-18 |
2006-12-12 |
Oxford Biomedica (Uk) Limited |
Polypeptide
|
|
US6210922B1
(en)
*
|
1998-11-30 |
2001-04-03 |
National Research Council Of Canada |
Serum free production of recombinant proteins and adenoviral vectors
|
|
HUP0104794A3
(en)
|
1998-12-31 |
2006-03-28 |
Centelion |
Method for separating viral particles
|
|
FR2788064B1
(fr)
*
|
1998-12-31 |
2003-01-31 |
Aventis Pharma Sa |
Methode de separation de particules virales
|
|
WO2000050573A1
(fr)
|
1999-02-22 |
2000-08-31 |
Transgene S.A. |
Procede d'obtention d'une preparation virale purifiee
|
|
US6795585B1
(en)
|
1999-07-16 |
2004-09-21 |
Eastman Kodak Company |
Representing digital images in a plurality of image processing states
|
|
JP2003518380A
(ja)
*
|
1999-12-29 |
2003-06-10 |
ジェンザイム・コーポレイション |
核酸および他の細胞性汚染混入物質からウイルスベクターを分離するための濾過助剤の使用方法
|
|
US6168941B1
(en)
*
|
2000-04-07 |
2001-01-02 |
Genvec, Inc. |
Method of producing adenoviral vector stocks
|
|
EP1280409A4
(en)
*
|
2000-04-28 |
2004-05-19 |
Zengen Inc |
A GENTHERAPY SYSTEM AND METHOD USING ALPHA-MSH AND ITS DERIVATIVES
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
TWI289158B
(en)
*
|
2000-08-10 |
2007-11-01 |
Oncolytics Biotech Inc |
Method of producing infectious reovirus
|
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
|
US20020064860A1
(en)
*
|
2000-11-29 |
2002-05-30 |
Schering Corporation |
Method for purifying adenoviruses
|
|
DK2253701T3
(da)
*
|
2001-03-16 |
2014-10-20 |
Oncolytics Biotech Inc |
Fremgangsmåde til ekstraktion af en virus fra en cellekultur
|
|
US20040146590A1
(en)
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
|
KR100947911B1
(ko)
*
|
2001-03-27 |
2010-03-17 |
버텍스 파마슈티칼스 인코포레이티드 |
Ｈｃｖ 감염에 유용한 조성물 및 방법
|
|
US7319002B2
(en)
|
2001-08-08 |
2008-01-15 |
The Trustees Of The University Of Pennsylvania |
Method for purification of viral vectors having proteins which bind sialic acid
|
|
AU2002332736A1
(en)
*
|
2001-08-30 |
2003-03-18 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of |
New adenovirus type 7 vectors
|
|
US7045335B2
(en)
*
|
2001-09-06 |
2006-05-16 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
WO2003039459A2
(en)
*
|
2001-11-05 |
2003-05-15 |
Genvec, Inc. |
Viral vector production methods and compositions
|
|
US7056723B2
(en)
*
|
2001-12-20 |
2006-06-06 |
Bavarian Nordic A/S |
Method for the recovery and purification of poxviruses from infected cells
|
|
KR100451308B1
(ko)
*
|
2001-12-28 |
2004-10-06 |
선바이오(주) |
단백질 의약품 정제 방법에서의 바이러스 제거 방법
|
|
US7041500B2
(en)
*
|
2002-02-14 |
2006-05-09 |
Novavax, Inc. |
Insect cell line
|
|
WO2003070891A2
(en)
*
|
2002-02-20 |
2003-08-28 |
Merck & Co., Inc. |
Method of determining adenovirus particle concentration
|
|
US20030175688A1
(en)
*
|
2002-03-15 |
2003-09-18 |
Rukmini Pennathur-Das |
Method for the purification and production of oncolytic adenoviruses
|
|
US20030186832A1
(en)
*
|
2002-03-15 |
2003-10-02 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Isotropic liquid detergents with improved anti-redeposition
|
|
US20030180936A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Memarzadeh Bahram Eric |
Method for the purification, production and formulation of oncolytic adenoviruses
|
|
US20050118701A1
(en)
*
|
2002-03-29 |
2005-06-02 |
Weichang Zhou |
Large scale methods of producing adenovirus and adenovirus seed stocks
|
|
JP2005523722A
(ja)
|
2002-04-30 |
2005-08-11 |
オンコリティクス バイオテック， インコーポレイティッド |
改善されたウイルス精製方法
|
|
ATE360683T1
(de)
*
|
2002-05-14 |
2007-05-15 |
Merck & Co Inc |
Verfahren zur reinigung von adenovirus
|
|
US20030224354A1
(en)
*
|
2002-05-30 |
2003-12-04 |
Introgen Therapeutics Inc. |
Quantifying viral particles with intrinsic fluorescence
|
|
EP1371723A1
(en)
*
|
2002-06-12 |
2003-12-17 |
Procorde GmbH |
Process for preparing an adenovirus-containing preparation
|
|
US20040219516A1
(en)
*
|
2002-07-18 |
2004-11-04 |
Invitrogen Corporation |
Viral vectors containing recombination sites
|
|
EP1585964A4
(en)
*
|
2002-08-28 |
2008-07-16 |
Introgen Therapeutics Inc |
CHROMATOGRAPHIC METHODS FOR PURIFYING ADENOVIRUSES
|
|
BR0315053A
(pt)
*
|
2002-10-03 |
2005-08-09 |
Targegen Inc |
Agentes vasculostáticos , composição, artigo e processo de preparação dos mesmos
|
|
US20050282814A1
(en)
*
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
US7319021B2
(en)
*
|
2002-11-01 |
2008-01-15 |
Promega Corporation |
Cell lysis composition, methods of use, apparatus and kit
|
|
EP1585812B1
(en)
|
2002-12-13 |
2017-01-18 |
Alphavax, Inc. |
Multi-antigenic alphavirus replicon particles and methods
|
|
JP5079981B2
(ja)
*
|
2002-12-13 |
2012-11-21 |
アルファバックス，インコーポレイティド |
アルファウイルス粒子及び調製方法
|
|
US20040225077A1
(en)
|
2002-12-30 |
2004-11-11 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
WO2004064785A2
(en)
|
2003-01-14 |
2004-08-05 |
Dana Farber Cancer Institute |
Cancer therapy sensitizer
|
|
KR101518309B1
(ko)
*
|
2003-03-20 |
2015-05-08 |
알파벡스, 인크. |
개선된 알파바이러스 레플리콘 및 헬퍼 구축물
|
|
DE602004008451T2
(de)
*
|
2003-05-01 |
2008-05-15 |
Dsm Ip Assets B.V. |
Verfahren zur herstellung von biologischen substanzen durch perfusionskultivierung von suspendierten tierischen zellen
|
|
US20040229335A1
(en)
*
|
2003-05-15 |
2004-11-18 |
Introgen Therapeutics, Inc. |
Methods and compositions for the production of adenoviral vectors
|
|
JP2007523621A
(ja)
*
|
2003-06-18 |
2007-08-23 |
オニックス ファーマシューティカルズ，インコーポレイティド |
ウイルスを精製するための方法
|
|
EP1651666B1
(en)
*
|
2003-07-11 |
2009-05-27 |
Alphavax, Inc. |
Alphavirus-based cytomegalovirus vaccines
|
|
DE602004031681D1
(de)
|
2003-07-21 |
2011-04-14 |
Transgene Sa |
Multifunktionelle Cytokine
|
|
US8304189B2
(en)
*
|
2003-12-01 |
2012-11-06 |
Life Technologies Corporation |
Nucleic acid molecules containing recombination sites and methods of using the same
|
|
CA2551026A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Schering Corporation |
Methods for producing a549 cell lines stable in serum-free medium suspension culture
|
|
ES2329607T3
(es)
*
|
2004-02-23 |
2009-11-27 |
Crucell Holland B.V. |
Metodos de purificacion de virus.
|
|
CN100333797C
(zh)
*
|
2005-01-26 |
2007-08-29 |
彭朝晖 |
重组腺病毒p53制品在肿瘤治疗中的新用途
|
|
US7456176B2
(en)
*
|
2004-04-08 |
2008-11-25 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
|
ES2321212T3
(es)
|
2004-05-18 |
2009-06-03 |
Alphavax, Inc. |
Vectores alfavirus derivados de tc-83, particulas y metodos antecentes de la invencion.
|
|
BRPI0511764B8
(pt)
*
|
2004-06-01 |
2021-05-25 |
Avigen Inc |
método de prevenção de agregação de vírions de vírus adeno-associado recombinante (raav) em uma preparação purificada de virions raav
|
|
US20050287616A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Gross Adam F |
Method of assaying denaturation of proteins
|
|
US7652051B2
(en)
|
2004-08-25 |
2010-01-26 |
Targegen, Inc. |
Heterocyclic compounds and methods of use
|
|
DE202004014949U1
(de)
*
|
2004-09-25 |
2004-11-18 |
Techno-Grafica Gmbh |
Vorrichtung zum Wärmebehandeln einer Beschichtung von Flachoffset-Druckplatten
|
|
DE102004049290A1
(de)
*
|
2004-10-09 |
2006-04-20 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von Virusmaterial
|
|
US7901921B2
(en)
*
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
CA2586107A1
(en)
*
|
2004-11-03 |
2006-05-18 |
Introgen Therapeutics Inc. |
A novel method for the production and purification of adenoviral vectors
|
|
CN100497640C
(zh)
*
|
2004-11-26 |
2009-06-10 |
中国人民解放军军事医学科学院生物工程研究所 |
一种高效生产重组腺病毒载体的方法
|
|
US20060166364A1
(en)
*
|
2004-12-22 |
2006-07-27 |
Introgen, Inc. |
Use of flexible bag containers for viral production
|
|
DK2368975T3
(en)
*
|
2004-12-23 |
2015-01-05 |
Medimmune Llc |
Non-tumorigenic MDCK cell line for the propagation of viruses
|
|
US20060205080A1
(en)
*
|
2005-03-01 |
2006-09-14 |
David Frey |
Formulations for therapeutic viruses having enhanced storage stability
|
|
EP3312196B1
(en)
|
2005-03-23 |
2019-07-17 |
Genmab A/S |
Antibodies against cd38 for treatment of multiple myeloma
|
|
US8574595B2
(en)
*
|
2005-04-11 |
2013-11-05 |
Crucell Holland B.V. |
Virus purification using ultrafiltration
|
|
CN101184780B
(zh)
*
|
2005-05-05 |
2012-10-03 |
森馨香料公司 |
β-葡聚糖和甘露聚糖的制备
|
|
CA2611720A1
(en)
*
|
2005-06-08 |
2006-12-14 |
Targegen, Inc. |
Methods and compositions for the treatment of ocular disorders
|
|
WO2007005885A2
(en)
*
|
2005-07-05 |
2007-01-11 |
David Nance |
Energy recovery within a fluid distribution network using geographical information
|
|
US8604042B2
(en)
*
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US7528143B2
(en)
*
|
2005-11-01 |
2009-05-05 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
EP2005185B1
(en)
*
|
2006-03-22 |
2010-10-20 |
Viral Logic Systems Technology Corp. |
Methods for identifying polypeptide targets
|
|
WO2007127366A2
(en)
*
|
2006-04-25 |
2007-11-08 |
Targegen, Inc. |
Kinase inhibitors and methods of use thereof
|
|
KR101464783B1
(ko)
*
|
2006-09-15 |
2014-11-26 |
메디뮨 엘엘씨 |
높은 역가로 바이러스 증식을 지원하는 ｍｄｃｋ 세포주 및 이를 이용한 생물반응기 공정
|
|
PE20081723A1
(es)
|
2007-01-30 |
2008-12-14 |
Transgene Sa |
Vacuna contra el papilomavirus
|
|
US20080299624A1
(en)
*
|
2007-06-01 |
2008-12-04 |
Edward Heslop |
Continuous fermentation apparatus and method
|
|
DK2183368T3
(en)
|
2007-06-21 |
2016-09-05 |
Alphavax Inc |
PROMOTER-FREE CASES FOR EXPRESSION OF ALPHAVIRUS STRUCTURE PROTEINS
|
|
RU2484132C2
(ru)
*
|
2007-10-08 |
2013-06-10 |
Интрексон Корпорейшн |
Модифицированные дендритные клетки и их применение в лечении злокачественных опухолей
|
|
PT2222697E
(pt)
|
2007-11-01 |
2013-02-15 |
Perseid Therapeutics Llc |
Polipeptídeos imunossupressores e ácidos nucleicos
|
|
US20090253184A1
(en)
*
|
2008-01-23 |
2009-10-08 |
Introgen Therapeutics, Inc. |
Compositions and methods related to an adenoviral trans-complementing cell line
|
|
WO2009140374A2
(en)
|
2008-05-13 |
2009-11-19 |
Gen-Probe Incorporated |
Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences
|
|
WO2009153563A1
(en)
*
|
2008-06-18 |
2009-12-23 |
Oxford Biomedica (Uk) Limited |
Virus purification
|
|
KR20110074563A
(ko)
*
|
2008-09-24 |
2011-06-30 |
메디뮨 엘엘씨 |
바이러스의 정제 방법
|
|
KR20110074564A
(ko)
|
2008-09-24 |
2011-06-30 |
메디뮨 엘엘씨 |
세포 배양, 바이러스 증식 및 바이러스 정제를 위한 방법
|
|
WO2010060719A1
(en)
|
2008-11-03 |
2010-06-03 |
Crucell Holland B.V. |
Method for the production of adenoviral vectors
|
|
AU2009319979B2
(en)
*
|
2008-11-03 |
2016-10-20 |
Takeda Vaccines, Inc. |
Improved methods for isolating enveloped virus-based VLPs free of infectious agents
|
|
JP2012528274A
(ja)
*
|
2009-05-26 |
2012-11-12 |
レビアサン エナジー ウインド ロータス エルティディー． |
流体発電用イン・パイプ・タービン
|
|
CN103335931A
(zh)
*
|
2009-07-07 |
2013-10-02 |
索尼公司 |
微流体装置
|
|
BR112012002628B1
(pt)
|
2009-08-07 |
2021-09-08 |
Transgene Sa |
Composição imunogênica, molécula de ácido nucleico, vetor, partícula viral infecciosa, micro-organismo transgênico, composição, usos da composição imunogênica e kit de partes
|
|
PL2488636T3
(pl)
|
2009-10-15 |
2014-07-31 |
Crucell Holland Bv |
Sposób oczyszczania cząsteczek adenowirusów z hodowli o wysokim zagęszczeniu komórkowym
|
|
CN102575233B
(zh)
|
2009-10-15 |
2014-07-16 |
克鲁塞尔荷兰公司 |
从高细胞密度培养物纯化腺病毒的方法
|
|
KR101810257B1
(ko)
|
2010-01-05 |
2017-12-18 |
바스큘라 바이오제닉스 리미티드 |
아교모세포종 ｇｂｍ을 치료하기 위한 조성물 및 방법
|
|
NZ601324A
(en)
|
2010-01-05 |
2014-10-31 |
Vascular Biogenics Ltd |
Methods for use of a specific anti-angiogenic adenoviral agent
|
|
SG182490A1
(en)
*
|
2010-01-12 |
2012-08-30 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
|
KR101820980B1
(ko)
|
2010-02-15 |
2018-01-22 |
얀센 백신스 앤드 프리벤션 비.브이. |
Ａｄ 26 아데노바이러스 벡터를 제조하는 방법
|
|
JP2013523175A
(ja)
|
2010-04-14 |
2013-06-17 |
イーエムディー・ミリポア・コーポレーション |
高力価、高純度のウイルスストックの作製方法及びその使用方法
|
|
CN103052399B
(zh)
|
2010-08-12 |
2016-06-29 |
依生生物制药控股有限公司 |
用于减少病毒组合物中dna杂质的方法
|
|
CN103118702A
(zh)
|
2010-09-20 |
2013-05-22 |
克鲁塞尔荷兰公司 |
活动性结核病的治疗性接种
|
|
MX354752B
(es)
|
2010-09-27 |
2018-03-20 |
Janssen Vaccines & Prevention Bv |
Regimen de vacunacion de sensibilizacion y refuerzo heterologo contra malaria.
|
|
US8892184B2
(en)
|
2010-10-18 |
2014-11-18 |
Siemens Medical Solutions Usa, Inc. |
Systems and methods for reducing interference in a dual modality imaging system
|
|
WO2012060847A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
EP2461162A1
(en)
|
2010-12-03 |
2012-06-06 |
Texcell, . |
Method for determining the titre of viruses by using infectious standards
|
|
CN105821078A
(zh)
|
2010-12-09 |
2016-08-03 |
巴斯德研究所 |
用于获得高产量重组蛋白表达的基于mgmt的方法
|
|
TWI623618B
(zh)
|
2011-07-12 |
2018-05-11 |
傳斯堅公司 |
Ｈｂｖ聚合酶突變體
|
|
WO2013045658A1
(en)
|
2011-09-29 |
2013-04-04 |
Transgene Sa |
Immunotherapy composition and regimen for treating hepatitis c virus infection
|
|
WO2013045668A2
(en)
|
2011-09-29 |
2013-04-04 |
Transgene Sa |
Immunotherapy composition and regimen for treating hepatitis c virus infection
|
|
US20130122038A1
(en)
|
2011-11-14 |
2013-05-16 |
The United States Of America As Represented By The Secretary Of The Department |
Heterologous prime-boost immunization using measles virus-based vaccines
|
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
SI2825640T1
(sl)
|
2012-03-12 |
2016-08-31 |
Crucell Holland B.V. |
Šarže rekombinantnega adenovirusa s spremenjenimi konci
|
|
MY169352A
(en)
|
2012-03-22 |
2019-03-25 |
Janssen Vaccines & Prevention Bv |
Vaccine against rsv
|
|
US9125870B2
(en)
|
2012-03-22 |
2015-09-08 |
Crucell Holland B.V. |
Vaccine against RSV
|
|
CA2878898C
(en)
*
|
2012-07-26 |
2023-01-17 |
Vectalys |
Method for detecting or measuring the impact of a viral vector composition on eukaryotic cells and biomarkers used thereof
|
|
EP3587455A1
(en)
|
2012-10-23 |
2020-01-01 |
Emory University |
Gm-csf and il-4 conjugates, compositions, and methods related thereto
|
|
AU2014259474B2
(en)
|
2013-04-25 |
2018-09-13 |
Janssen Vaccines & Prevention B.V. |
Stabilized soluble prefusion RSV F polypeptides
|
|
MY181753A
(en)
|
2013-05-03 |
2021-01-06 |
Honeywell Int Inc |
Lead frame construct for lead-free solder connections
|
|
CN105408348B
(zh)
|
2013-06-17 |
2021-07-06 |
扬森疫苗与预防公司 |
稳定化的可溶性融合前rsv f多肽
|
|
US9956166B2
(en)
|
2013-09-18 |
2018-05-01 |
Sorrento Therapeutics, Inc. |
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
|
|
WO2015062699A1
(en)
*
|
2013-10-30 |
2015-05-07 |
Merck Patent Gmbh |
Method for isolating microorganisms from a complex sample
|
|
KR20160121562A
(ko)
|
2014-02-20 |
2016-10-19 |
허니웰 인터내셔날 인코포레이티드 |
무연 솔더 조성물
|
|
US11008547B2
(en)
|
2014-03-25 |
2021-05-18 |
Terumo Bct, Inc. |
Passive replacement of media
|
|
JP6571679B2
(ja)
|
2014-04-25 |
2019-09-04 |
トランスレイト バイオ， インコーポレイテッド |
メッセンジャーｒｎａの精製方法
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
CN105316296A
(zh)
*
|
2014-06-13 |
2016-02-10 |
亚宝药业太原制药有限公司 |
一种纯化腺病毒颗粒的方法
|
|
EP3191507A1
(en)
|
2014-09-09 |
2017-07-19 |
Unum Therapeutics |
Chimeric receptors and uses thereof in immune therapy
|
|
GB201417042D0
(en)
|
2014-09-29 |
2014-11-12 |
Fkd Therapies Oy |
Method
|
|
CN107106689A
(zh)
|
2014-11-05 |
2017-08-29 |
沃雅戈治疗公司 |
用于治疗帕金森病的aadc多核苷酸
|
|
CN112410338A
(zh)
|
2014-11-14 |
2021-02-26 |
沃雅戈治疗公司 |
调节性多核苷酸
|
|
IL292999A
(en)
|
2014-11-14 |
2022-07-01 |
Voyager Therapeutics Inc |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
WO2016094783A1
(en)
|
2014-12-12 |
2016-06-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
|
CN107428799A
(zh)
*
|
2015-01-13 |
2017-12-01 |
阿尔法韦士曼公司 |
纯化腺相关病毒(AAV)及/或重组腺相关病毒(rAAV)之方法及其梯度和流通式缓冲液
|
|
EP3054007A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
|
|
ES3011733T3
(en)
|
2015-02-13 |
2025-04-08 |
Transgene |
Immunotherapeutic vaccine and antibody combination therapy
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
CA2981841A1
(en)
|
2015-04-14 |
2016-10-20 |
Janssen Vaccines & Prevention B.V. |
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
|
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
|
CA2991002C
(en)
|
2015-07-07 |
2023-11-28 |
Janssen Vaccines & Prevention B.V. |
Vaccine against rsv
|
|
JP6840718B2
(ja)
|
2015-07-07 |
2021-03-10 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． |
安定化された可溶性融合前ｒｓｖ ｆポリペプチド
|
|
US9663766B2
(en)
*
|
2015-07-24 |
2017-05-30 |
Bio-Rad Laboratories, Inc. |
Methods for purifying adenovirus vectors
|
|
AU2016337525B2
(en)
|
2015-10-16 |
2022-01-20 |
The Trustees Of Columbia University In The City Of New York |
Compositions and methods for inhibition of lineage specific antigens
|
|
EP3368054A4
(en)
|
2015-10-28 |
2019-07-03 |
Voyager Therapeutics, Inc. |
REGULATORY EXPRESSION USING THE ADENO-ASSOCIATED VIRUS (AAV)
|
|
KR102500970B1
(ko)
|
2016-04-05 |
2023-02-17 |
얀센 백신스 앤드 프리벤션 비.브이. |
Rsv에 대한 백신
|
|
PT3439672T
(pt)
|
2016-04-05 |
2021-02-24 |
Janssen Vaccines & Prevention Bv |
Proteína f do rsv pré-fusão solúvel e estabilizada para uso na profilaxia de infeção por rsv
|
|
SG11201808698TA
(en)
*
|
2016-04-14 |
2018-11-29 |
Trizell Ltd |
Fixed-bed bioreactor with constant-flow pump/ tubing system
|
|
CN116144500A
(zh)
*
|
2016-04-14 |
2023-05-23 |
崔泽尔有限公司 |
具有恒流泵/管道系统的固定床生物反应器
|
|
US11326182B2
(en)
|
2016-04-29 |
2022-05-10 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
WO2017189964A2
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
EP3452081A1
(en)
|
2016-05-04 |
2019-03-13 |
Transgene SA |
Combination therapy with cpg tlr9 ligand
|
|
KR20220108216A
(ko)
|
2016-05-18 |
2022-08-02 |
보이저 테라퓨틱스, 인크. |
헌팅톤 질환을 치료하기 위한 조성물 및 방법
|
|
SG11201809699XA
(en)
|
2016-05-18 |
2018-12-28 |
Voyager Therapeutics Inc |
Modulatory polynucleotides
|
|
WO2017205667A1
(en)
|
2016-05-25 |
2017-11-30 |
Terumo Bct, Inc. |
Cell expansion
|
|
KR102421049B1
(ko)
|
2016-05-30 |
2022-07-15 |
얀센 백신스 앤드 프리벤션 비.브이. |
안정화된 융합-전 rsv f 단백질
|
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
|
CN109312362B
(zh)
|
2016-06-20 |
2022-06-28 |
扬森疫苗与预防公司 |
有效和平衡的双向启动子
|
|
US10744196B2
(en)
|
2016-07-14 |
2020-08-18 |
Janssen Vaccines & Prevention B.V. |
HPV vaccines
|
|
CN110650673B
(zh)
|
2016-08-30 |
2024-04-09 |
加利福尼亚大学董事会 |
用于生物医学靶向和递送的方法以及用于实践该方法的装置和系统
|
|
EP3522920A2
(en)
|
2016-10-10 |
2019-08-14 |
Transgene SA |
Immunotherapeutic product and mdsc modulator combination therapy
|
|
WO2018080573A1
(en)
|
2016-10-28 |
2018-05-03 |
Massachusetts Institute Of Technology |
Crispr/cas global regulator screening platform
|
|
US10294452B2
(en)
|
2016-11-22 |
2019-05-21 |
Dao-Yao He |
Lysis, extraction and purification of adeno-associated virus and adenovirus from host cells
|
|
CN108085301B
(zh)
*
|
2016-11-22 |
2021-10-26 |
贺道耀 |
从宿主细胞提取和纯化腺相关病毒和腺病毒的方法及其组分和试剂盒
|
|
US20210405031A1
(en)
*
|
2016-12-08 |
2021-12-30 |
Temple University - Of The Commonwealth System Of Higher Education |
Small animal models for in vivo testing of polyomavirus therapeutics
|
|
WO2018148246A1
(en)
|
2017-02-07 |
2018-08-16 |
Massachusetts Institute Of Technology |
Methods and compositions for rna-guided genetic circuits
|
|
WO2018184028A2
(en)
|
2017-03-31 |
2018-10-04 |
Terumo Bct, Inc. |
Cell expansion
|
|
SG11201909870SA
(en)
|
2017-05-05 |
2019-11-28 |
Voyager Therapeutics Inc |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
JP2020518259A
(ja)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
ハンチントン病治療組成物および方法
|
|
JP2020519663A
(ja)
|
2017-05-17 |
2020-07-02 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． |
Ｒｓｖ感染に対する防御免疫を誘導するための方法及び組成物
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
JP7229989B2
(ja)
|
2017-07-17 |
2023-02-28 |
ボイジャー セラピューティクス インコーポレイテッド |
軌道アレイガイドシステム
|
|
TWI832036B
(zh)
|
2017-08-03 |
2024-02-11 |
美商航海家醫療公司 |
用於aav之遞送之組合物及方法
|
|
CN107384873A
(zh)
*
|
2017-09-05 |
2017-11-24 |
成都汇宇生物技术有限公司 |
重组腺病毒的纯化方法
|
|
US11229695B2
(en)
|
2017-09-15 |
2022-01-25 |
Janssen Vaccines & Prevention B.V. |
Method for the safe induction of immunity against RSV
|
|
MX2020003042A
(es)
|
2017-09-29 |
2020-11-18 |
Voyager Therapeutics Inc |
Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
|
|
EP4454654A3
(en)
|
2017-10-16 |
2025-02-19 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
|
US11434502B2
(en)
|
2017-10-16 |
2022-09-06 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (ALS)
|
|
JP7432506B2
(ja)
|
2017-10-30 |
2024-02-16 |
武田薬品工業株式会社 |
脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
|
|
WO2019092084A1
(en)
*
|
2017-11-08 |
2019-05-16 |
Blue Sky Vaccines Gmbh |
So3 chromatography for use in a method for virus purification
|
|
US20210010028A1
(en)
|
2018-03-06 |
2021-01-14 |
Voyager Therapeutics, Inc. |
Insect cell manufactured partial self-complementary aav genomes
|
|
US12129476B2
(en)
|
2018-04-27 |
2024-10-29 |
Voyager Therapeutics, Inc. |
Methods for measuring the potency of AADC viral vectors
|
|
WO2019222329A1
(en)
|
2018-05-15 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
EP3794126A1
(en)
|
2018-05-15 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of parkinson's disease
|
|
EP3793615A2
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Directed evolution of aav to improve tropism for cns
|
|
EP3793686A1
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
CA3103963A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
AU2019299439C1
(en)
|
2018-07-03 |
2025-06-26 |
Sotio Biotech, Inc. |
Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereof
|
|
JP2021530548A
(ja)
|
2018-07-24 |
2021-11-11 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics, Inc. |
遺伝子治療製剤を生産するための系および方法
|
|
JP7456638B2
(ja)
|
2018-08-14 |
2024-03-27 |
ソティオ，リミティド ライアビリティ カンパニー |
クレブス回路を調節するトランス代謝分子と組み合わせたキメラ抗原受容体ポリペプチド、及び、それらの治療的使用
|
|
EP3837035B1
(en)
|
2018-08-16 |
2026-05-20 |
Emd Millipore Corp |
Closed bioprocessing device
|
|
WO2020047164A1
(en)
|
2018-08-28 |
2020-03-05 |
Vor Biopharma, Inc |
Genetically engineered hematopoietic stem cells and uses thereof
|
|
EP3833398A4
(en)
|
2018-09-21 |
2021-12-22 |
University of Connecticut |
COMPOSITIONS AND METHODS OF RESTORING PATERNAL UBE3A GENE EXPRESSION IN ANGELMAN'S SYNDROME IN HUMANS
|
|
CN113383010B
(zh)
|
2018-09-28 |
2025-09-09 |
沃雅戈治疗公司 |
具有经工程化改造的启动子的共济蛋白表达构建体及其使用方法
|
|
EP3861010A1
(en)
|
2018-10-02 |
2021-08-11 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
|
TW202035689A
(zh)
|
2018-10-04 |
2020-10-01 |
美商航海家醫療公司 |
測量病毒載體粒子的效價及強度之方法
|
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
CN113164583A
(zh)
|
2018-11-13 |
2021-07-23 |
扬森疫苗与预防公司 |
稳定的融合前rsv f蛋白
|
|
WO2020123524A1
(en)
*
|
2018-12-11 |
2020-06-18 |
Erbi Biosystems, Inc. |
Methods of manufacturing cell based products using small volume perfusion processes
|
|
MX2021008542A
(es)
|
2019-01-18 |
2021-11-12 |
Voyager Therapeutics Inc |
Métodos y sistemas para la producción de partículas de aav.
|
|
CN113710810A
(zh)
|
2019-02-21 |
2021-11-26 |
安利舒免疫溶瘤技术公司 |
溶瘤腺病毒载体和使用方法
|
|
CN110093455B
(zh)
*
|
2019-04-27 |
2020-03-17 |
中国医学科学院病原生物学研究所 |
一种呼吸道病毒的检测方法
|
|
WO2020223274A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
|
|
WO2020227515A1
(en)
|
2019-05-07 |
2020-11-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation
|
|
CN112175996A
(zh)
*
|
2019-07-05 |
2021-01-05 |
杭州荣泽生物科技有限公司 |
一种基因治疗载体的制备方法和用途
|
|
US20220290182A1
(en)
|
2019-08-09 |
2022-09-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
WO2021041485A1
(en)
|
2019-08-26 |
2021-03-04 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2021046155A1
(en)
|
2019-09-03 |
2021-03-11 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
|
WO2021097366A1
(en)
*
|
2019-11-15 |
2021-05-20 |
City Of Hope |
System, device and method for production of bioproduct including high density cell respirator for intensified production of adeno-associated viruses
|
|
CN110894494B
(zh)
*
|
2019-11-22 |
2022-09-27 |
广西梧州制药（集团）股份有限公司 |
一种大规模高密度悬浮培养293细胞高产腺病毒的方法
|
|
WO2021202651A1
(en)
|
2020-04-01 |
2021-10-07 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
|
BR112022020753A2
(pt)
|
2020-04-15 |
2022-12-20 |
Voyager Therapeutics Inc |
Compostos de ligação a tau
|
|
GB202005732D0
(en)
|
2020-04-20 |
2020-06-03 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
|
AU2021273447B2
(en)
|
2020-05-13 |
2026-03-05 |
Voyager Therapeutics, Inc. |
Redirection of tropism of AAV capsids
|
|
WO2022032153A1
(en)
|
2020-08-06 |
2022-02-10 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
GB202013940D0
(en)
|
2020-09-04 |
2020-10-21 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
|
CN112226418B
(zh)
*
|
2020-09-25 |
2022-07-08 |
阜外华中心血管病医院 |
重组腺相关病毒纯化方法
|
|
WO2022076556A2
(en)
|
2020-10-07 |
2022-04-14 |
Asklepios Biopharmaceutical, Inc. |
Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy disorders including limb girdle 2i (lgmd2i)
|
|
CN112293394B
(zh)
*
|
2020-10-30 |
2022-11-25 |
海南德安欣有害生物防治科技有限公司 |
一种捕鼠装置及捕鼠方法
|
|
US20230407328A1
(en)
|
2020-11-02 |
2023-12-21 |
Biomarin Pharmaceutical Inc. |
Process for enriching adeno-associated virus
|
|
GB202019454D0
(en)
*
|
2020-12-10 |
2021-01-27 |
Chancellor Masters And Scholars Of The Univ Of Oxford |
Method for purifying virus
|
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
EP4301768A2
(en)
|
2021-03-03 |
2024-01-10 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
CA3216491A1
(en)
|
2021-04-16 |
2022-10-20 |
Asklepios Biopharmaceutical, Inc. |
Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response
|
|
WO2023034980A1
(en)
|
2021-09-03 |
2023-03-09 |
Bomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
US20250122530A1
(en)
|
2021-09-03 |
2025-04-17 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
US20240384242A1
(en)
|
2021-09-03 |
2024-11-21 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
WO2023034990A1
(en)
|
2021-09-03 |
2023-03-09 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
EP4396201A1
(en)
|
2021-09-03 |
2024-07-10 |
BioMarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
US20240376496A1
(en)
|
2021-09-03 |
2024-11-14 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
EP4405396A2
(en)
|
2021-09-20 |
2024-07-31 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
|
JP2024536859A
(ja)
|
2021-09-27 |
2024-10-08 |
ソティオ バイオテック インコーポレイティド |
解糖経路からグルコース代謝産物を再誘導するトランス代謝分子と組み合わせたキメラ受容体ポリペプチド及びその治療的使用
|
|
IL311861A
(en)
|
2021-11-02 |
2024-06-01 |
Voyager Therapeutics Inc |
Aav capsid variants and uses thereof
|
|
AU2022388928A1
(en)
|
2021-11-16 |
2024-05-16 |
Sotio Biotech Inc. |
Treatment of myxoid/round cell liposarcoma patients
|
|
US20250011372A1
(en)
|
2021-11-17 |
2025-01-09 |
Voyager Thrapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
US20250059527A1
(en)
|
2021-12-16 |
2025-02-20 |
University Of Dundee |
Targeted degradation of alpha-synuclein
|
|
US20250346920A1
(en)
|
2022-01-25 |
2025-11-13 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
|
AU2023217698A1
(en)
|
2022-02-08 |
2024-07-25 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
GB202201713D0
(en)
|
2022-02-10 |
2022-03-30 |
Univ Dundee |
An affinity directed phosphatase system for targeted protein dephosphorylation
|
|
CN115354033A
(zh)
*
|
2022-03-25 |
2022-11-18 |
上海碧博生物医药科技有限公司 |
一种细胞裂解液、细胞裂解方法及该方法在收获aav的应用
|
|
EP4532515A1
(en)
|
2022-06-02 |
2025-04-09 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
US20250215453A1
(en)
|
2022-06-28 |
2025-07-03 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2024011112A1
(en)
|
2022-07-06 |
2024-01-11 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2024040207A1
(en)
|
2022-08-19 |
2024-02-22 |
Sotio Biotech Inc. |
Genetically engineered natural killer (nk) cells with chimeric receptor polypeptides in combination with trans metabolism molecules and therapeutic uses thereof
|
|
WO2024040208A1
(en)
|
2022-08-19 |
2024-02-22 |
Sotio Biotech Inc. |
Genetically engineered immune cells with chimeric receptor polypeptides in combination with multiple trans metabolism molecules and therapeutic uses thereof
|
|
US20260085328A1
(en)
|
2022-09-08 |
2026-03-26 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
CN120019071A
(zh)
|
2022-09-15 |
2025-05-16 |
沃雅戈治疗公司 |
Tau结合化合物
|
|
TW202421788A
(zh)
|
2022-09-22 |
2024-06-01 |
美商拜奧馬林製藥公司 |
用ａａｖ基因療法載體治療致心律不整性心肌病
|
|
KR20250108100A
(ko)
|
2022-09-22 |
2025-07-15 |
디나코 아게 |
Aav 유전자 치료법 벡터를 이용한 심근병증의 치료
|
|
EP4694916A1
(en)
|
2023-04-14 |
2026-02-18 |
SOTIO Biotech Inc. |
Engineered immune cells for treating cancer in combination with il-2/il-15 receptor ?? agonists
|
|
WO2024215987A1
(en)
|
2023-04-14 |
2024-10-17 |
Sotio Biotech Inc. |
IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-15/IL-15Rα CONJUGATES
|
|
WO2024226790A1
(en)
|
2023-04-26 |
2024-10-31 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
AU2024265526A1
(en)
|
2023-05-03 |
2025-12-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2024229173A2
(en)
|
2023-05-03 |
2024-11-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to ataxin-2
|
|
EP4705317A1
(en)
|
2023-05-03 |
2026-03-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to cdkl5 deficiency
|
|
WO2024229164A2
(en)
|
2023-05-03 |
2024-11-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
EP4705488A1
(en)
|
2023-05-04 |
2026-03-11 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2025030010A1
(en)
|
2023-08-01 |
2025-02-06 |
Vor Biopharma Inc. |
Compositions comprising genetically engineered hematopoietic stem cells and methods of use thereof
|
|
WO2025038430A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2025038796A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to cdkl5 deficiency
|
|
WO2025038805A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2025038800A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to frataxin deficiency
|
|
WO2025038795A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2025038802A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to ataxin-2
|
|
WO2025122548A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to cdkl5 deficiency
|
|
WO2025122536A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2025122530A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2025122532A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to ataxin-2
|
|
WO2025122543A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to syntaxin-binding protein 1 deficiency
|
|
TW202540436A
(zh)
|
2023-12-05 |
2025-10-16 |
美商航海家醫療公司 |
用於治療與共濟蛋白(frataxin)缺陷相關之病症之組合物及方法
|
|
WO2025137219A1
(en)
|
2023-12-21 |
2025-06-26 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2025147436A1
(en)
|
2024-01-03 |
2025-07-10 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
CN117551624A
(zh)
*
|
2024-01-11 |
2024-02-13 |
深圳源兴基因技术有限公司 |
一种基于无血清悬浮扩增的高效回收腺病毒的方法
|
|
WO2025214477A1
(en)
|
2024-04-12 |
2025-10-16 |
Skyline Therapeutics (Shanghai) Co., Ltd. |
Treatment of genetic cardiomyopathies with aav gene therapy vectors
|
|
WO2026028089A1
(en)
|
2024-07-29 |
2026-02-05 |
Novartis Ag |
Compositions and methods for the treatment of lysosomal acid lipase deficiency (lal-d)
|
|
WO2026096599A1
(en)
|
2024-10-30 |
2026-05-07 |
Neurocrine Biosciences, Inc. |
Compositions and methods for delivering syntaxin-binding protein-1
|
|
WO2026096603A1
(en)
|
2024-10-30 |
2026-05-07 |
Neurocrine Biosciences, Inc. |
Compositions and methods for delivering syntaxin-binding protein-1
|
|
WO2026096611A1
(en)
|
2024-10-30 |
2026-05-07 |
Neurocrine Biosciences, Inc. |
Compositions and methods for delivering cyclin-dependent kinase-like 5 protein
|
|
WO2026096600A1
(en)
|
2024-10-30 |
2026-05-07 |
Neurocrine Biosciences, Inc. |
Compositions and methods for delivering cyclin-dependent kinase-like 5 protein
|